China Pilot of ICOPE (Integrated Care for Older People) in Chaoyang

NCT05933798 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 2148

Last updated 2023-07-06

No results posted yet for this study

Summary

The goal of this pilot study is to examine predefined parameters (sample size, capacity building, acceptance by community-dwelling older people (participants) and care providers) to evaluate the feasibility of implementing World Health Organization's ICOPE (integrated care for older people) approach in China. The main questions it aims to answer are:

1. Whether it is feasible to implement the ICOPE approach in China;
2. Whether the integrated care approach would make any difference in health outcomes and resource utilization.

Participating older adults receiving integrated care (Intervention Group) are compared to those receiving usual care (Control Group) in order to answer the two questions above.

Conditions

  • Aging
  • Healthy Aging
  • Utilization, Health Care

Interventions

OTHER

ICOPE

The ICOPE approach with locally adapted care pathways was implemented by trained integrated care managers (ICMs) advised by multi-disciplinary teams, delivered in primary care settings

OTHER

Usual Care

Participants in the Control Group would have their care plan after assessment and seek health and care services as usual without additional advice or support on implementing the care plan

Sponsors & Collaborators

  • Peking Union Medical College Hospital

    collaborator OTHER
  • Pinetree Health Technologies (Beijing) Co., Ltd.

    lead INDUSTRY

Principal Investigators

  • Ninie Wang, MBA DrPH · Pinetree Care Group

Study Design

Allocation
RANDOMIZED
Purpose
HEALTH_SERVICES_RESEARCH
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
60 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-09-01
Primary Completion
2021-07-31
Completion
2021-08-31

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05933798 on ClinicalTrials.gov